Pathogenesis of thrombophilia in the Japanese population.
Naotaka Hamasaki
Abstract
Open-access reader
Naotaka Hamasaki
Abstract
Open-access reader
By using a screening program to clarify the etiology of thrombophilia, we found protein S deficiency, either congenital or acquired, to be an important pathogenesis of thrombosis in the Japanese population. A gene analysis revealed that about one third of the patients with a low protein S activity are associated with varied mutations in the PROS 1 gene. Protein S (PS) is a nonenzymatic cofactor for activated protein C (APC) and plays an integral role as a regulator of APC that inhibits coagulation by enzymatically cleaving the activated forms of factor V and factor VIII. Approximately 60% of plasma PS circulates as a complex with C4b binding protein (C4BP), while the remainder circulates as free PS. Since only free PS has APC cofactor activity, a reduction in free PS is considered to be a cause of plasma PS deficiency. Factor V Leiden (R506Q) is resistant to the protein C/protein S anticoagulant pathway and is found in 20% to 60% of Caucasian patients with venous thrombosis. In Japan, no thrombotic patient having the factor V Leiden gene has been observed, instead, the decreased PS activity was found with a high incidence in thrombotic patients.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
By using a screening program to clarify the etiology of thrombophilia, we found protein S deficiency, either congenital or acquired, to be an important pathogenesis of thrombosis in the Japanese population. A gene analysis revealed that about one third of the patients with a low protein S activity are associated with varied mutations in the PROS 1 gene. Protein S (PS) is a nonenzymatic cofactor for activated protein C (APC) and plays an integral role as a regulator of APC that inhibits coagulation by enzymatically cleaving the activated forms of factor V and factor VIII. Approximately 60% of plasma PS circulates as a complex with C4b binding protein (C4BP), while the remainder circulates as free PS. Since only free PS has APC cofactor activity, a reduction in free PS is considered to be a cause of plasma PS deficiency. Factor V Leiden (R506Q) is resistant to the protein C/protein S anticoagulant pathway and is found in 20% to 60% of Caucasian patients with venous thrombosis. In Japan, no thrombotic patient having the factor V Leiden gene has been observed, instead, the decreased PS activity was found with a high incidence in thrombotic patients.
Key concepts: Protein S, Protein C, Pathogenesis, Thrombophilia, Coagulation, Factor V Leiden, Protein S deficiency, Factor V